Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
March 21, 2024
Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease
Fiona Day, Swetha Sridharan, Catherine Johnson, et al.
Implementation Science : IS
|
March 5, 2021
Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres
Christine L Paul, Graham Warren, Shalini Vinod, et al.
Health Services & Outcomes Research Methodology
|
October 4, 2022
Building staff capability, opportunity, and motivation to provide smoking cessation to people with cancer in Australian cancer treatment centres: development of an implementation intervention framework for the Care to Quit cluster randomised controlled trial
Annika Ryan, Alison Luk Young, Jordan Tait, et al.
Annals of Medicine and Surgery (2012)
|
June 8, 2026
Predicting recurrence patterns and outcomes following resection of pancreatic ductal adenocarcinoma: a contemporary real-world data cohort study
Eden Mane, Mark Tacey, Ben Loveday, et al.
BMC Cancer
|
December 17, 2022
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)
Fiona Day, Swetha Sridharan, James Lynam, et al.
Biomaterials
|
November 19, 2018
In vitro placenta barrier model using primary human trophoblasts, underlying connective tissue and vascular endothelium
Akihiro Nishiguchi, Catherine Gilmore, Aman Sood, et al.
The Medical Journal of Australia
|
January 11, 2024
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study
Luke S McLean, Annette M Lim, Mathias Bressel, et al.
Internal Medicine Journal
|
May 28, 2021
Business as unusual: medical oncology services adapt and deliver during COVID-19
Avraham Travers, Kim Adler, Gillian Blanchard, et al.
BMC Cancer
|
June 2, 2016
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours
Eva Segelov, Paul Waring, Jayesh Desai, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 6, 2025
Smoking Cessation Practices in Australian Oncology Settings: A Cross-Sectional Study of Who, How, and When
Alison Luk Young, Melissa McEnallay, Fiona Day, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Asia-Pacific Journal of Clinical Oncology
|
March 21, 2024
Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease
Fiona Day, Swetha Sridharan, Catherine Johnson, et al.
Implementation Science : IS
|
March 5, 2021
Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres
Christine L Paul, Graham Warren, Shalini Vinod, et al.
Health Services & Outcomes Research Methodology
|
October 4, 2022
Building staff capability, opportunity, and motivation to provide smoking cessation to people with cancer in Australian cancer treatment centres: development of an implementation intervention framework for the Care to Quit cluster randomised controlled trial
Annika Ryan, Alison Luk Young, Jordan Tait, et al.
Annals of Medicine and Surgery (2012)
|
June 8, 2026
Predicting recurrence patterns and outcomes following resection of pancreatic ductal adenocarcinoma: a contemporary real-world data cohort study
Eden Mane, Mark Tacey, Ben Loveday, et al.
BMC Cancer
|
December 17, 2022
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)
Fiona Day, Swetha Sridharan, James Lynam, et al.
Biomaterials
|
November 19, 2018
In vitro placenta barrier model using primary human trophoblasts, underlying connective tissue and vascular endothelium
Akihiro Nishiguchi, Catherine Gilmore, Aman Sood, et al.
The Medical Journal of Australia
|
January 11, 2024
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study
Luke S McLean, Annette M Lim, Mathias Bressel, et al.
Internal Medicine Journal
|
May 28, 2021
Business as unusual: medical oncology services adapt and deliver during COVID-19
Avraham Travers, Kim Adler, Gillian Blanchard, et al.
BMC Cancer
|
June 2, 2016
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours
Eva Segelov, Paul Waring, Jayesh Desai, et al.
Asia-Pacific Journal of Clinical Oncology
|
February 6, 2025
Smoking Cessation Practices in Australian Oncology Settings: A Cross-Sectional Study of Who, How, and When
Alison Luk Young, Melissa McEnallay, Fiona Day, et al.
Page
of 4